News: HLS Australia's Healius rejects $1 bln buyout offer by Australian Clinical Labs

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    May 4 (Reuters) - Australia's medical centre operator Healius (HLS) on Thursday recommended that its shareholders reject the A$1.52 billion ($1.01 billion) all-share takeover offer by Australian Clinical Labs (ACL) .

    The offer, made in March, has "no cash and no premium" and is "plainly inadequate", Healius said in its statement.

    ($1 = 1.5047 Australian dollars)

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
84.5¢
Change
0.005(0.60%)
Mkt cap ! $613.5M
Open High Low Value Volume
83.5¢ 86.5¢ 81.5¢ $3.101M 3.675M

Buyers (Bids)

No. Vol. Price($)
1 9 84.5¢
 

Sellers (Offers)

Price($) Vol. No.
85.0¢ 49196 5
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
HLS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.